No Data
Express News | [Change Report] KDDI Corporation reports an increase in Shareholding percentage of Newtech (6734.JP) to 9.27%.
＜Today's individual materials＞ Veru Inc, Iore, Resonac, and Dainippon Ink and Chemicals, etc. (Announcement on the 26th)
▽Liberata <4935.T> has obtained a patent in Japan for the "clothing cooling mist" developed in collaboration with Taffrey International, related to the "cooling agent composition". ▽Iore <2334.T> has started a new business in Cryptos financial services and an Artificial Intelligence (AI) Datacenter business. ▽Resonac <4004.T> expects a significant decrease in operating profit for the fiscal year ending December 2025 (IFRS). ▽Dainippon Seika <4116.T> has projected a net profit for the consolidated fiscal year ending March 2025.
Resona Holdings turned profitable with an operating profit of 89 billion yen for the fiscal year ending December 2024, while the Financial Estimates for December 2025 predict a 45.0% decrease to 49 billion yen.
Resonac HD <4004> announced its performance for the fiscal year ending December 2024, with revenue increasing by 7.4% year-on-year to 1 trillion 391.4 billion 80 million yen, and an operating profit of 89 billion 36 million yen (compared to a loss of 9.4 billion 7 million yen in the previous period). For the fiscal year ending December 2025, revenue is projected to increase by 2.2% year-on-year to 1 trillion 422 billion yen, while operating profit is planned to decrease by 45% to 49 billion yen. 【Positive Evaluation】 <4644> Imagineer Correction | 【Hold】 <4116> Dainippon Screen.
Key points of attention for PTS on the 26th = Imagineer, Basis, Yamaha, ETC.
▽ Imaginia <4644.T> has raised its consolidated net profit Financial Estimates for the fiscal year ending March 2025, and has also increased its Dividends Financial Estimates. ▽ Basis <4068.T> has introduced a shareholder incentive program. ▽ Yamaha <7951.T> has announced its stock buyback. ▽ Oncoress B <4588.T> has received a patent grant for a patent related to the administration method of 'tumor lytic virus OBP-301'. ▽ Isin <143A.T> is set to make human resources consulting firm Repser a subsidiary. ▽ Quest <2332.T> is developing a business application.
Newtech: Notice regarding revisions to full-year consolidated earnings forecasts
Newtech Cuts FY Net View to Y267.00M